Belite Bio, Inc is a clinical-stage biopharmaceutical drug development company. The company's pipeline of therapies is built on its RBP4 (Retinol Binding Protein 4) IP portfolio. Belite Bio is focused on meeting the unmet needs of patients suffering from blindness, liver disease, and diabetes. The company operates as a subsidiary of Lin Bioscience International Ltd. Belite Bio was founded in 2016 and is based in San Diego, CA.
What is Belite Bio's quote symbol?
What is the 52 week high and low for Belite Bio (NASDAQ: BLTE)?
How much is Belite Bio stock worth today?
How much is Belite Bio's stock price per share?
What is Belite Bio's Market Cap?